A blockbuster unleashed: What happens when a big fat business explodes?

India is set to experience a dramatic shift as Ozempic and Wegovy's active ingredient, semaglutide, becomes widely available. Over 40 Indian companies are launching affordable generic versions, slashing prices and expanding access. This transition promises to address major health challenges but also raises concerns about potential misuse and the need for strong oversight.